Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Astal Laboratories Limited

Market Cap 2.76B 28.82M 25.01M 23.05M 21.6M 40.36M 41.2M 275M 106M 1.33B 108M 106M 4.62B P/E Ratio 2024
26.3x
P/E Ratio 2025 9.45x
Enterprise Value 2.87B 30.02M 26.05M 24.01M 22.5M 42.04M 42.92M 286M 111M 1.39B 113M 110M 4.82B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
38.01%
Yield 2024 *
-
Yield 2025 -
1 day-0.62%
1 week+7.47%
Current month+4.64%
1 month-6.10%
3 months+4.33%
6 months-5.79%
Current year-11.02%
1 week 69.1
Extreme 69.1
81
1 month 65.45
Extreme 65.45
84.36
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 22.41
Extreme 22.41
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Compliance Officer 32 19/04/2023
Director TitleAgeSince
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%+7.47%-9.42%+153.38% 35.48M
-1.06%+1.62%+41.59%+158.20% 1,035B
+0.43%+2.69%+52.57%+49.48% 574B
-0.05%-1.03%+16.88%+63.29% 397B
+0.60%+0.77%+21.19%+15.95% 324B
-0.65%-3.10%+21.74%+13.51% 281B
+0.68%+3.54%+24.56%+34.48% 278B
+1.46%+5.17%-44.91%-47.71% 193B
+0.39%+1.19%+18.99%+62.75% 191B
-0.66%-3.59%+11.13%+59.93% 156B
Average -0.03%+2.94%+15.43%+56.33% 343B
Weighted average by Cap. -0.18%+2.39%+28.12%+72.31%

Financials

2024 2025
Net sales 237M 2.47M 2.14M 1.98M 1.85M 3.46M 3.53M 23.58M 9.13M 114M 9.28M 9.08M 397M 637M 6.65M 5.77M 5.32M 4.98M 9.31M 9.5M 63.44M 24.56M 307M 24.96M 24.42M 1.07B
Net income 7.85M 81.95K 71.12K 65.56K 61.43K 115K 117K 782K 303K 3.78M 308K 301K 13.15M 89.25M 932K 809K 746K 699K 1.31M 1.33M 8.89M 3.44M 43.02M 3.5M 3.42M 150M
Net Debt -57.64M -602K -522K -482K -451K -843K -861K -5.74M -2.22M -27.79M -2.26M -2.21M -96.61M 115M 1.21M 1.05M 964K 903K 1.69M 1.72M 11.5M 4.45M 55.62M 4.52M 4.43M 193M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
12/06/26 77.28 -0.62% 30,727
11/06/26 77.76 +3.86% 75,780
10/06/26 74.87 +4.71% 24,063
09/06/26 71.50 +0.36% 9,035
08/06/26 71.24 -0.93% 17,546
  1. Stock Market
  2. Stocks
  3. 512600 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!